- Email: [email protected]
Novozymes collaborates in Brazilian second-generation bioethanol projects
FOCUS catalysts business of Nippon Shokubai Co Ltd has reported total sales of Yen 29.32 bn (Yen 23.34 bn for its fiscal 2005), operating income of Yen 2.98 bn (Yen 3.12 bn), and capital investments of Yen 370 M (Yen 394 M). Sales of automotive catalysts increased as surging precious metal pricing increased sales prices. Sales of wastewater treatment plant equipment and catalysts increased due to sales of large-scale equipment in overseas markets. Sales of process catalyst decreased due to declining replacement demand. Sales of DeNOx catalysts, waste gas treatment equipment, and catalysts were roughly flat year-over-year. Operating income in the environment and catalysts business decreased by 4.5% due to higher raw materials costs and a weaker product mix. Nippon Shokubai Annual Consolidated Business Results 2007 (Year-end 31 Mar 2007), 8 May 2007, 7,17 (Nippon Shokubai Co Ltd, Kogin Bldg, 4-1-1 Koraibashi, Chuo-ku, Osaka 541-0043, Japan. Website: http://www.shokubai.co.jp/eng/)
Solid growth over 1H 2007 for Novozymes Novozymes’ sales for 1H 2007 totalled DKR 3734 M (+14%). Sales rose by 12% in Europe, by 22% in North America, by 15% in Latin America, and by 6% in Asia. Operating profit for 1H 2007 was DKR 788 M (+20%). Six graphs show sales for Novozymes’ various business, including detergent enzymes (+13% to DKR 1127 M); technical enzymes (+17% to DKR 1079 M); food enzymes (+6% to DKR 836 M); feed enzymes (+1% to DKR 346 M); microorganisms (-5% to DKR 175 M); and biopharmaceutical ingredients (DKR 171 M, up from DKR 44 M in 1H 2006). The Zymes (Novozymes’ Shareholder Magazine), Sep 2007, (2), 8-9 (Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. E-mail: [email protected]. Website: http://www.novozymes.com)
Novozymes: enzymatic endeavours Novozymes South Asia Pvt Ltd (Novozymes), representing Novozymes of the Denmark-based Novo Nordisk group in India, is based in Bangalore. Novozymes has decided to set up a R&D unit in Bangalore to focus on optimising enzyme properties. Novozymes spends
4
ON
C ATA LY S T S
about 13% of its turnover on R&D and about 10% of this expenditure is used in new areas ie, beyond enzymes and micro organisms. BioSpectrum, Jun 2007, 5 (6), 74 (Website: http://www.biospectrumindia.com)
Novozymes collaborates in Brazilian second-generation bioethanol projects
are in talks about signing a technology agreement to develop enzymes for sugarcane bagasse-based ethanol production. No formal agreement has been reached between the two companies. Petrobras is eyeing the development of ethanol using bagasse cellulose. Converting the cellulose would require a specific enzyme manufactured by Novozymes.
Novozymes has entered into development agreements with the Brazilian cane sugar industry’s technical centre CTC (Centro de Tecnologia Canavieira) in which Novozymes will contribute enzyme technology for the production of bioethanol from bagasse, a waste product in the manufacture of sugar from sugar cane. There will be close collaboration between CTC and Novozymes in Brazil with the support of Novozymes’ research centres in the US and Denmark. In future this production process will give a higher yield of ethanol from cane sugar and will therefore optimize the process economics and energy balance while at the same time reducing the acreage cultivated and further reducing emissions of greenhouse gases.
BNAmericas Oil & Gas News, 12 Sep 2007 (Business News Americas Ltda. Website: http://www.bnamericas.com) & Press releases from: Petrobras and Novozymes, 11 Sep
Net Posten, 13 Sep 2007 (Website: http://www.netposten.dk/) (in Danish) & Press release from: Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. E-mail: [email protected]. Website: http://www.novozymes.com (13 Sep 2007)
SCR-Tech announces $650,000 order for catalyst regeneration services and a three-year SCR management contract
Detergent enzymes on the rise After several quiet years, sales of Novozymes’ enzymes for the laundry detergent industry are increasing, with 13% growth in 1H 2007. Reasons for the growth vary, including higher living standards in Asia and Latin America, Novozymes’ increasing its market share in Europe because of the introduction of new enzyme products, and increasing use of enzymes as replacements for petrochemicalbased ingredients in detergents. The Zymes (Novozymes’ Shareholder Magazine), Sep 2007, (2), 3 (Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. E-mail: [email protected]. Website: http://www.novozymes.com)
Petrobras, Novozymes discussing bagasse-to-ethanol deal: Brazil Brazil’s federal energy company Petrobras and Denmark’s Novozymes
Rossari Biotech: sales up for 2006-2007 The Mumbai-based industrial enzymes manufacturer Rossari Biotech India has posted revenues of Rup 1.07 bn, with biotech products accounting for Rup 660 M, for 2006-2007 (revenues of Rup 910 M, with biotech products contributing Rup 412 M in 20052006). The company has set up an R&D centre at Navi Mumbai with a state-of-the-art laboratory with qualified technocrats. BioSpectrum, Jun 2007, 5 (6), 83 (Website: http://www.biospectrumindia.com)
SCR-Tech, a subsidiary of Catalytica Energy Systems Inc, has secured contracts from two leading Midwestern utility customers, including an order totalling $650,000 to provide SCR catalyst regeneration services and a three-year SCR management contract. Under the first contract, SCR-Tech will clean and regenerate catalyst from an SCR system located at one of the customer’s coal-fired power plants. This process will extend the life of the catalyst, saving costs relating to the disposal of spent catalysts and buying new catalysts. In the second contract SCR-Tech will provide on-going evaluation and guidance on effective SCR system operation and catalyst management strategies, with the aim of assisting the customer to optimising SCR system performance. SCR-Tech’s customers are facing additional challenges relating to the onset of more stringent NOx emissions regulations and yearround SCR operation beginning in Jan
NOVEMBER 2007
Solid growth over 1H 2007 for Novozymes Novozymes’ sales for 1H 2007 totalled DKR 3734 M (+14%). Sales rose by 12% in Europe, by 22% in North America, by 15% in Latin America, and by 6% in Asia. Operating profit for 1H 2007 was DKR 788 M (+20%). Six graphs show sales for Novozymes’ various business, including detergent enzymes (+13% to DKR 1127 M); technical enzymes (+17% to DKR 1079 M); food enzymes (+6% to DKR 836 M); feed enzymes (+1% to DKR 346 M); microorganisms (-5% to DKR 175 M); and biopharmaceutical ingredients (DKR 171 M, up from DKR 44 M in 1H 2006). The Zymes (Novozymes’ Shareholder Magazine), Sep 2007, (2), 8-9 (Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. E-mail: [email protected]. Website: http://www.novozymes.com)
Novozymes: enzymatic endeavours Novozymes South Asia Pvt Ltd (Novozymes), representing Novozymes of the Denmark-based Novo Nordisk group in India, is based in Bangalore. Novozymes has decided to set up a R&D unit in Bangalore to focus on optimising enzyme properties. Novozymes spends
4
ON
C ATA LY S T S
about 13% of its turnover on R&D and about 10% of this expenditure is used in new areas ie, beyond enzymes and micro organisms. BioSpectrum, Jun 2007, 5 (6), 74 (Website: http://www.biospectrumindia.com)
Novozymes collaborates in Brazilian second-generation bioethanol projects
are in talks about signing a technology agreement to develop enzymes for sugarcane bagasse-based ethanol production. No formal agreement has been reached between the two companies. Petrobras is eyeing the development of ethanol using bagasse cellulose. Converting the cellulose would require a specific enzyme manufactured by Novozymes.
Novozymes has entered into development agreements with the Brazilian cane sugar industry’s technical centre CTC (Centro de Tecnologia Canavieira) in which Novozymes will contribute enzyme technology for the production of bioethanol from bagasse, a waste product in the manufacture of sugar from sugar cane. There will be close collaboration between CTC and Novozymes in Brazil with the support of Novozymes’ research centres in the US and Denmark. In future this production process will give a higher yield of ethanol from cane sugar and will therefore optimize the process economics and energy balance while at the same time reducing the acreage cultivated and further reducing emissions of greenhouse gases.
BNAmericas Oil & Gas News, 12 Sep 2007 (Business News Americas Ltda. Website: http://www.bnamericas.com) & Press releases from: Petrobras and Novozymes, 11 Sep
Net Posten, 13 Sep 2007 (Website: http://www.netposten.dk/) (in Danish) & Press release from: Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. E-mail: [email protected]. Website: http://www.novozymes.com (13 Sep 2007)
SCR-Tech announces $650,000 order for catalyst regeneration services and a three-year SCR management contract
Detergent enzymes on the rise After several quiet years, sales of Novozymes’ enzymes for the laundry detergent industry are increasing, with 13% growth in 1H 2007. Reasons for the growth vary, including higher living standards in Asia and Latin America, Novozymes’ increasing its market share in Europe because of the introduction of new enzyme products, and increasing use of enzymes as replacements for petrochemicalbased ingredients in detergents. The Zymes (Novozymes’ Shareholder Magazine), Sep 2007, (2), 3 (Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark. Tel: +45 8824 9999. Fax: +45 8824 9998. E-mail: [email protected]. Website: http://www.novozymes.com)
Petrobras, Novozymes discussing bagasse-to-ethanol deal: Brazil Brazil’s federal energy company Petrobras and Denmark’s Novozymes
Rossari Biotech: sales up for 2006-2007 The Mumbai-based industrial enzymes manufacturer Rossari Biotech India has posted revenues of Rup 1.07 bn, with biotech products accounting for Rup 660 M, for 2006-2007 (revenues of Rup 910 M, with biotech products contributing Rup 412 M in 20052006). The company has set up an R&D centre at Navi Mumbai with a state-of-the-art laboratory with qualified technocrats. BioSpectrum, Jun 2007, 5 (6), 83 (Website: http://www.biospectrumindia.com)
SCR-Tech, a subsidiary of Catalytica Energy Systems Inc, has secured contracts from two leading Midwestern utility customers, including an order totalling $650,000 to provide SCR catalyst regeneration services and a three-year SCR management contract. Under the first contract, SCR-Tech will clean and regenerate catalyst from an SCR system located at one of the customer’s coal-fired power plants. This process will extend the life of the catalyst, saving costs relating to the disposal of spent catalysts and buying new catalysts. In the second contract SCR-Tech will provide on-going evaluation and guidance on effective SCR system operation and catalyst management strategies, with the aim of assisting the customer to optimising SCR system performance. SCR-Tech’s customers are facing additional challenges relating to the onset of more stringent NOx emissions regulations and yearround SCR operation beginning in Jan
NOVEMBER 2007